MDS CLASSIFICATION & PROGNOSIS @AAMDSIF
MDS CLASSIFICATION & PROGNOSIS  @AAMDSIF
Uploaded June 2024 | Updated September 2026, 13 hours ago
Session from the 2024 International Bone Marrow Failure Scientific Symposium
Featured Speakers:
Mina Xu, MD - Yale University
MDS Classification: WHO vs. ICC

Lachelle Weeks, MD, PhD - Harvard University/Dana Farber Cancer Institute
Prognostication of CHIP and CCUS

Tariq Kewan, MD - Yale University
MDS Molecular Classification

Luca Lanino, MD - Humanitas Research Hospital & Humanitas University, ITALY
Harmonizing WHO and ICC MDS Classification

Andrew Brunner, MD - Massachusetts General HOSPITAL
MDS Response Criteria
MDS CLASSIFICATION & PROGNOSISAplastic Anemia and PNH: An Update on Diagnosis and TreatmentNew Drug Approval for PNH Patients - PiaSkySclerotic GVHDOcular GVHD   Diagnosis and TreatmentPediatric Nurse Finds her Way through Aplastic Anemia TreatmentLiving with PNH: Tamirs StoryBronchiolitis Obliterans / GVHD:TREATMENTS FOR MDS & SECONDARY AMLUpdates on Aplastic Anemia and PNH from ASH2021, ASCO2022, and EHA2022AML Session Summary for Patients with Mikkael Sekeres - Secondary AML and TransplantationAddressing Barriers and Challenges to Patient Care - 2023 Omaha Patient and Family Hybrid Conference
AAMDSIF |

MDS CLASSIFICATION & PROGNOSIS

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER